CRISCuris, Inc.

$15M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+24.1% YoY

Gross Profit

$3M99.5% margin

Operating Income

-$9M-268.9% margin

Net Income

-$10M-287.5% margin

EPS (Diluted)

$-1.25

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$41M

Total Liabilities

$47M

Stockholders' Equity

-$6M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+24.1%
Gross Profit	$3M	$3M	+26.0%
Operating Income	-$9M	-$12M	+26.3%
Net Income	-$10M	-$12M	+17.9%

CRIS Q4 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena